Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FU9XA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,298.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded to AmerisourceBergen Drug Corp on August 21, 2025, provides for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pen injectors with a contract ceiling value of $10,298.62. The award is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the Defense Logistics Agency (DLA), which is responsible for medical supply chain management across the Department of Defense. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this comprehensive IDC vehicle to supply pharmaceutical products and medical commodities supporting military healthcare systems worldwide. The parent IDC encompasses a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This specific delivery order for Zepbound reflects the contractor's role in supporting federal diabetes care programs within the military healthcare system through the DLA's flexible and extensive pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FU9XA?
SPE2DB25FU9XA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FU9XA worth?
The government has obligated $10,299 on SPE2DB25FU9XA.
Is contract SPE2DB25FU9XA an order under another contract?
Yes. SPE2DB25FU9XA is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9XA competed?
The extent of competition for SPE2DB25FU9XA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award